vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Caledonia Mining Corp Plc (CMCL). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $46.9M, roughly 1.8× Caledonia Mining Corp Plc). Caledonia Mining Corp Plc runs the higher net margin — 7.0% vs 6.8%, a 0.2% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 13.8%).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Hochschild Mining plc is a leading British-based silver and gold mining business operating in North, Central, and South America. It is headquartered in Lima, Peru, with a corporate office in London, is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The main shareholder is the Peruvian businessman Eduardo Hochschild.
BLLN vs CMCL — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $46.9M |
| Net Profit | $5.7M | $3.3M |
| Gross Margin | 69.9% | 41.2% |
| Operating Margin | 11.5% | 18.6% |
| Net Margin | 6.8% | 7.0% |
| Revenue YoY | 117.4% | 13.8% |
| Net Profit YoY | 138.3% | -33.3% |
| EPS (diluted) | $0.10 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $83.5M | — | ||
| Q3 24 | $38.4M | $46.9M | ||
| Q2 24 | — | $50.1M | ||
| Q1 24 | — | $38.5M | ||
| Q4 23 | — | $38.7M | ||
| Q3 23 | — | $41.2M | ||
| Q2 23 | — | $37.0M | ||
| Q1 23 | — | $29.4M |
| Q3 25 | $5.7M | — | ||
| Q3 24 | $-14.9M | $3.3M | ||
| Q2 24 | — | $10.2M | ||
| Q1 24 | — | $2.1M | ||
| Q4 23 | — | $-2.6M | ||
| Q3 23 | — | $4.9M | ||
| Q2 23 | — | $-2.5M | ||
| Q1 23 | — | $-4.6M |
| Q3 25 | 69.9% | — | ||
| Q3 24 | 52.6% | 41.2% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | — | 35.9% | ||
| Q4 23 | — | 27.3% | ||
| Q3 23 | — | 34.3% | ||
| Q2 23 | — | 29.5% | ||
| Q1 23 | — | 19.9% |
| Q3 25 | 11.5% | — | ||
| Q3 24 | -32.9% | 18.6% | ||
| Q2 24 | — | 32.2% | ||
| Q1 24 | — | 13.8% | ||
| Q4 23 | — | 6.0% | ||
| Q3 23 | — | 22.4% | ||
| Q2 23 | — | 2.5% | ||
| Q1 23 | — | -5.1% |
| Q3 25 | 6.8% | — | ||
| Q3 24 | -38.8% | 7.0% | ||
| Q2 24 | — | 20.3% | ||
| Q1 24 | — | 5.4% | ||
| Q4 23 | — | -6.7% | ||
| Q3 23 | — | 12.0% | ||
| Q2 23 | — | -6.8% | ||
| Q1 23 | — | -15.8% |
| Q3 25 | $0.10 | — | ||
| Q3 24 | $-1.47 | $0.13 | ||
| Q2 24 | — | $0.42 | ||
| Q1 24 | — | $0.07 | ||
| Q4 23 | — | $-0.19 | ||
| Q3 23 | — | $0.21 | ||
| Q2 23 | — | $-0.14 | ||
| Q1 23 | — | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $7.2M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $231.0M |
| Total Assets | $327.5M | $339.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $195.2M | — | ||
| Q3 24 | — | $7.2M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | — | $1.8M | ||
| Q4 23 | — | $6.7M | ||
| Q3 23 | — | $10.8M | ||
| Q2 23 | — | $12.8M | ||
| Q1 23 | — | $19.0M |
| Q3 25 | $55.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
| Q3 25 | $-239.5M | — | ||
| Q3 24 | $-242.9M | $231.0M | ||
| Q2 24 | — | $231.1M | ||
| Q1 24 | — | $220.3M | ||
| Q4 23 | — | $224.2M | ||
| Q3 23 | — | $226.6M | ||
| Q2 23 | — | $224.3M | ||
| Q1 23 | — | $223.4M |
| Q3 25 | $327.5M | — | ||
| Q3 24 | — | $339.7M | ||
| Q2 24 | — | $338.5M | ||
| Q1 24 | — | $321.8M | ||
| Q4 23 | — | $328.3M | ||
| Q3 23 | — | $320.3M | ||
| Q2 23 | — | $313.9M | ||
| Q1 23 | — | $320.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $4.6M |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $13.8M | — | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $19.1M | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | $14.5M | ||
| Q2 23 | — | $-2.2M | ||
| Q1 23 | — | — |
| Q3 25 | $6.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
| Q3 25 | 7.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
| Q3 25 | 8.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
| Q3 25 | 2.42× | — | ||
| Q3 24 | — | 1.40× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 2.94× | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
CMCL
Segment breakdown not available.
